SAR288 has emerged as a promising therapeutic target for COVID-19. This small molecule exhibits remarkable antiviral properties against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have demonstrated that SAR288 can effectively suppress viral replication in vitro and in vivo. Furthermore, SAR288 has shown favorable safety pro